The Money Times

<img alt="" height="1" width="1" />
US approves Shire&#39;s drug for Gaucher disease
WASHINGTON, Feb 26 (Reuters) - The US Food and Drug Administration approved Shire Plc&#39;s (SHP.L) (SHPGY.O) Vpriv drug on Friday to treat children and adults with the most common form of Gaucher disease. The injectable drug, which treats patients with ...
Vitamin D helps Gaucher disease patientsFood Consumer
New Drug for Genetic Disorder Gets Final FDA NodMedPage Today
Shire&#39;s Gaucher drug
eFitnessNow -SmartAboutHealth -The Associated Press
all 135 news articles &raquo;